BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20651198)

  • 1. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
    Ng CS; Shaw AD; Bell CS; Samuels JA
    AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
    Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
    Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
    Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Intravenous Administration of Contrast Media on Serum Creatinine Levels in Neonates.
    Bedoya MA; White AM; Edgar JC; Pradhan M; Raab EL; Meyer JS
    Radiology; 2017 Aug; 284(2):530-540. PubMed ID: 28387639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
    Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA
    AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate.
    McDonald JS; McDonald RJ; Carter RE; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2014 Apr; 271(1):65-73. PubMed ID: 24475854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography.
    Sandstede JJ; Roth A; Machann W; Kaupert C; Hahn D
    Eur J Radiol; 2007 Jul; 63(1):120-3. PubMed ID: 17317065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
    Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.
    Davenport MS; Khalatbari S; Cohan RH; Dillman JR; Myles JD; Ellis JH
    Radiology; 2013 Sep; 268(3):719-28. PubMed ID: 23579046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
    Fananapazir G; Troppmann C; Corwin MT; Nikpour AM; Naderi S; Lamba R
    Abdom Radiol (NY); 2016 Nov; 41(11):2182-2186. PubMed ID: 27377897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
    Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
    AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxic Polypharmacy and Risk of Contrast Medium-Induced Nephropathy in Hospitalized Patients Undergoing Contrast-Enhanced CT.
    Ho YF; Hsieh KL; Kung FL; Wu FL; Hsieh LL; Chou H; Chen SJ
    AJR Am J Roentgenol; 2015 Oct; 205(4):703-8. PubMed ID: 26397318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cystatin C and serum creatinine for the diagnosis of contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography at an oncology centre.
    Fortalesa Melo JI; Chojniak R; Costa Silva DH; Oliveira Junior JC; Vieira Bitencourt AG; Holanda Silva D; GuimarĂ£es MD; Silva HC; Dias DG; Rodrigues WC; Brancucci EL; Cruz BM; Schiavon BN; Argenton JL; Camporini MA; Zocchio A
    PLoS One; 2015; 10(5):e0122877. PubMed ID: 25961558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravenous low-osmolality iodinated contrast media on patients with myasthenia gravis.
    Somashekar DK; Davenport MS; Cohan RH; Dillman JR; Ellis JH
    Radiology; 2013 Jun; 267(3):727-34. PubMed ID: 23360741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
    Karlsberg RP; Dohad SY; Sheng R;
    J Vasc Interv Radiol; 2011 Aug; 22(8):1159-65. PubMed ID: 21570871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
    McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Split Renal Function Using a Combination of Contrast-Enhanced CT and Serum Creatinine Values for Glomerular Filtration Rate Estimation.
    Shi W; Liang X; Wu N; Zhang H; Yuan X; Tan Y
    AJR Am J Roentgenol; 2020 Jul; 215(1):142-147. PubMed ID: 32255686
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration.
    Chou SH; Wang ZJ; Kuo J; Cabarrus M; Fu Y; Aslam R; Yee J; Zimmet JM; Shunk K; Elicker B; Yeh BM
    Eur J Radiol; 2011 Nov; 80(2):378-86. PubMed ID: 21470810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels.
    Herts BR; Schneider E; Poggio ED; Obuchowski NA; Baker ME
    Radiology; 2008 Jul; 248(1):106-13. PubMed ID: 18458249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.